Publications

5891 Results

Phase II into III

Authors
M Redman;B Goldman;M Leblanc
Journal / Conference
Journal of Thoracic Oncology, 6(6):Supplement 2, abstract M11.4, p. S92; International Assn for the Study of Lung Cancer, 14th World Conf on Lung Cancer (July 3-7, Amsterdam), invited oral presentation
Year
2011
Research Committee(s)
Lung

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

Authors
AJ Vickers;C Till;H Lilja;IM Thompson
Journal / Conference
Journal of the National Cancer Institute 103(6):462-469
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection [Commentary]

Authors
AJ Vickers
Journal / Conference
Journal of the Nationadld Cancer Institute 103(21):1635-1636
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Gastric Cancer: Nagoya is not New York [PMID22010021]

Authors
J Macdonald
Journal / Conference
Journal of Clinical Oncology 29(33):4348-4350
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials [PMID20595245; PMC3474201]

Authors
A Schroen;GR Petroni;H Wang;M Thielen;D Sargent;J Benedetti;WM Cronin;DL Wickerham;XF Wang;R Gray;WF Cohn;CL Slingluff;B Djulbegovic
Journal / Conference
Clinical Trials 8(5):591-600
Year
2011
Research Committee(s)
Multiple sites

A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK intercontinental trial CRUKE/01/013

Authors
L Klotz;CJ O'Callaghan;K Ding;DP Dearnaley;CS Higano;EM Horwitz;S Malone;SL Goldenberg;M Gospodarowicz;JM Crook
Journal / Conference
Journal of Clinical Oncology 29:2011 (suppl 7; abstr 3); ASCO GU symposium (poster presentation)
Year
2011
Research Committee(s)
Genitourinary

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

Authors
P Warde;M Mason;K Ding;P Kirkbride;M Brundage;R Cowan;M Gospodarowicz;E Kostashuk;G Swanson;J Barber;A Hiltz;MK Parmer;J Sathya;J Anderson;J Hetherington;MR Sydes;W Parulekar
Journal / Conference
Lancet 378(9809):2104-2111
Year
2011
Research Committee(s)
Genitourinary
PMID
PMID22056152
PMC
PMC3243932
Study Number(s)
JPR3

Randomized phase III trial of 131 iodine-tositumomab (Bexxar)/carmustine, etoposide, cytarabine, melphalan (BEAM) vs. rituximab/BEAM and autologous stem cell transplantation for relapsed diffuse large B-cell lymphoma (DLBCL): no difference in progression-free (PFS) or overall survival (OS)

Authors
JM Vose;SL Carter;LJ Burns;E Ayala;O Press;C Moskowitz;EA Stadtmauer;S Mineishi;RF Ambinder;TS Fenske;M Horowitz;M Tomblyn
Journal / Conference
Blood 118:abstract 661 (oral presentation)
Year
2011
Research Committee(s)
Lymphoma

Extended results of Southwest Oncology Group protocol S0232: durable responses achieved with lenalidomide (L) plus high-dose dexamethason (D) as first-line therapy for multiple myeloma

Authors
J Zonder;J Crowley;M Hussein;R Sexton;A Hoering;A Abidi;B Durie;B Barlogie
Journal / Conference
Haematologica 96(s1):S78, poster #167 (International Myeloma Workshop)
Year
2011
Research Committee(s)
Myeloma
Study Number(s)
S0232

How comparativeness effectiveness research can help advance "personalized medicine" in cancer treatment

Authors
S Ramsey;D Veenstra;S Tunis;L Garrison;J Crowley;L Baker
Journal / Conference
Health Affairs 30(12):2259-2268
Year
2011
Research Committee(s)
Breast
PMID
PMID22147853
PMC
PMC3477796
Study Number(s)
S1007